MarketPulse

clinical pipeline

6 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Proqr Therapeutics N.V.

ProQR Expands Pipeline With Multiple Clinical Catalysts Lined Up Through 2027

ProQR Therapeutics expands pipeline with lead program AX-0810 targeting H1 2026 data readout in biliary atresia, supported by three additional programs advancing through 2027.
LLYPRQRDNAHurler syndromeclinical pipeline
BenzingaBenzinga··Vandana Singh

Merck Bets $838M on Infinimmune's AI-Powered Antibody Platform

Merck partners with Infinimmune for next-gen antibody drugs, gaining exclusive rights to candidates from AI-powered platform with up to $838M in potential milestone payments.
MRKTERNbiotech partnershipmachine learning
BenzingaBenzinga··Prnewswire

Co-Diagnostics Reports Sharp Revenue Decline, $46.9M Loss as Cash Reserves Dwindle

Co-Diagnostics ($CODX) posted $0.6M revenue and $46.9M net loss in 2025, down from prior year, amid strategic joint ventures and pipeline advancement.
CODXfinancial resultscommercialization
BenzingaBenzinga··Vandana Singh

Nanobiotix Shoots Down J&J Acquisition Rumors, Stock Soars on Clarity

Nanobiotix denies J&J acquisition rumors, shares rise 6.17%. Stock up 774.83% annually; reaffirms focus on advancing cancer pipeline, NBTXR3 partnership.
JNJNBTXcancer treatmentbiotechnology
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Evaxion Schedules 2026 AGM as AI-Powered Vaccine Pipeline Advances

Danish biotech $EVAX announces April 2026 Annual General Meeting in Copenhagen while advancing AI-driven cancer and infectious disease vaccines.
EVAXAnnual General Meetingclinical pipeline
BenzingaBenzinga··Vandana Singh

CRISPR Therapeutics Posts Strong Gene Therapy Gains as Casgevy Adoption Accelerates

CRISPR Therapeutics reports strong Q4 results with Casgevy gene therapy generating $116M revenue and 147 patient initiations, signaling accelerating adoption and market confidence.
LLYVRTXREGNCRSPARWRsickle cell diseaseCasgevy